Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin testing and BAT in healthy volunteers to establish method for determining causative drug of perioperative anaphylaxis (preliminary study)
jRCT1031240042Recruiting
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefmetazole, chlorhexidine, midazolam and remimazolam in anaphylaxis, sponsored by Grants-in-Aid for Scientific Research. Started May 2024; status: recruiting.
02
Drugs
cefmetazolechlorhexidinemidazolamremimazolam
03
Conditions
anaphylaxis
Beyond the preview
Go deeper on jRCT1031240042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240042.